This study is in progress, not accepting new patients
A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome
a study on Dravet Syndrome Seizure Disorder
Summary
- Eligibility
- for people ages 2-18 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- Joseph Sullivan
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Joseph Sullivan
Associate Professor, Neurology. Authored (or co-authored) 17 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
- ID
- NCT02682927
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated